Nektar Therapeutics Financial Ratios — NKTR Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-92.89	-140.39	- -	- -	-379.68	-324.73	-109.91	75.47	-28.22	-35.8	-59.64	-70.39	-110.95	-124.1	-217.94
Return on Assets (%)	-23.76	-31.12	-34.75	-12.31	-17.27	-28.76	-17.94	51.25	-21.35	-25.28	-39.45	-40.29	-49.8	-33.9	-56.17
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	63.02	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	59.76	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	69.37	62.52	74.14	85.78	85.22	81.74	90.07	97.95	81.35	87.26	75.57	76.5	62.53	68.82	100
EBITDA Margin (%)	-152.47	-153.98	-71.08	-1.77	-7.16	-58.94	-9.4	58.56	-372.44	-239.18	-423.87	-246.82	-141.38	-127.53	-234.91
Operating Margin (%)	-173.39	-171.85	-80.67	-8.21	-12.73	-68.22	-14.19	57.65	-383.92	-248.45	-437.76	-260.97	-150.05	-131.99	-236.77
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	82.61	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-186.01	-211.17	-107.28	-27.12	-34.96	-92.27	-31.22	57.21	-383.93	-290.32	-513.49	-396.48	-306.54	-121.1	-281.52
Profit Margin (%)	-187.43	-211.67	-108.79	-26.86	-35.17	-92.8	-31.42	57.09	-384.47	-290.65	-514.03	-399.98	-306.31	-120.86	-297.07
Net Income to Common Margin (%)	-187.43	-211.67	-108.79	-26.86	-35.17	-92.8	-31.42	57.09	-384.47	-290.65	-514.03	-399.98	-306.31	-120.86	-297.07
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	0.21	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-92.89	-140.39	- -	- -	-379.68	-324.73	-109.91	75.47	-28.22	-35.8	-59.64	-70.39	-110.95	-124.1	-217.94

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	230	137	137	134	248	246	245	247	408	150	143	131	118	103	86
ST Debt	215	- -	4	5	5	3	- -	- -	265	14	17	19	19	20	20
LT Debt	15	137	133	129	243	243	245	247	143	136	126	113	99	83	65
Total Debt/EBITDA	-2.11	-1.09	-1.29	-37.56	-14.99	-2.53	-8.48	0.35	-0.96	-0.41	-0.33	-0.58	-0.92	-0.82	-0.66
Net Debt/EBITDA	-1.83	-0.8	-0.81	-31.66	-11.27	-1.89	-8.31	0.07	-0.37	0.54	0.06	0.39	0.28	0.35	0.12
Total Debt/EBIT	-1.85	-0.98	-1.14	-8.11	-8.43	-2.18	-5.62	0.36	-0.93	-0.4	-0.32	-0.55	-0.87	-0.79	-0.66
Net Debt/EBIT	-1.61	-0.71	-0.72	-6.83	-6.34	-1.63	-5.51	0.08	-0.36	0.52	0.06	0.37	0.26	0.34	0.12
EBITDA to Interest Expense	-10.66	-3.73	-2.6	-0.09	-0.42	-2.31	-0.71	16.34	-9.21	-9.85	-9.13	-7.86	-5.03	-4.47	-4.96
EBITDA-CapEx/Interest Expense	-11.61	-4.04	-2.7	-0.35	-0.71	-2.46	-0.94	16	-9.78	-10.05	-9.45	-8.06	-5.06	-4.52	-4.96
EBIT to Interest Expense	-12.12	-4.16	-2.95	-0.43	-0.76	-2.68	-1.07	16.08	-9.49	-10.24	-9.43	-8.31	-5.34	-4.62	-4.99
Interest Expense	10	34	41	39	39	42	41	43	46	37	47	29	25	28	26
Common Equity/Total Assets	32.61	9.45	-20.69	8.23	1.29	15.49	17.26	79.88	71.07	70.01	60.82	51.6	32.91	19.99	32.04
Long-Term Debt/Equity (%)	7.37	290.54	- -	355.44	3,776.2	276.27	279.19	14.38	10.16	12.66	18.5	30.77	75.21	136.15	72.64
Long-Term Debt/Capital (%)	3.41	74.39	285.01	75.97	95.6	72.79	73.63	12.57	7.87	11.11	15.28	22.65	39.6	50.64	37.17
Long-Term Debt/Total Assets (%)	2.4	27.44	30.62	29.24	48.69	42.8	48.19	11.49	7.22	8.86	11.25	15.88	24.75	27.22	23.27
Total Debt/Equity (%)	116.04	290.54	-151.92	367.86	3,850.18	279.57	279.19	14.38	29.04	13.95	21.07	35.87	89.91	168.87	95.46
Total Debt/Capital (%)	53.71	74.39	292.59	78.63	97.47	73.65	73.63	12.57	22.51	12.24	17.4	26.4	47.34	62.81	48.84
Total Debt/Total Assets (%)	37.84	27.44	31.43	30.26	49.64	43.31	48.19	11.49	20.64	9.77	12.82	18.5	29.59	33.75	30.58
Net Debt to Equity	100.93	211.76	-95.58	310.02	2,895.15	208.59	273.77	3.03	11.14	-18.47	-3.71	-24.06	-26.93	-72.86	-16.83
Net Debt/Capital (%)	48.45	62.94	1,128.47	71.46	93.82	66.88	73.25	2.94	9.12	-19.34	-3.16	-21.52	-16.52	-37.17	-9.42
EBITDA	-109	-125	-106	-4	-17	-98	-29	699	-427	-366	-432	-227	-127	-126	-130
EBITDA-CapEx	-119	-136	-110	-14	-28	-104	-39	685	-453	-373	-447	-233	-128	-127	-130
Operating Income (Loss)	-124	-140	-120	-16	-29	-113	-44	688	-440	-380	-446	-240	-135	-130	-131

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.88	3.53	2.41	3.71	5.04	5.39	5.27	16.28	3.74	9.17	8.61	7.4	5.92	4.16	4.59
Current Ratio	1	4.01	2.63	4.5	5.72	5.9	5.82	17.53	4.02	9.83	9.34	8	6.45	4.26	4.97
Quick Ratio	0.89	3.6	2.44	3.77	5.37	5.6	5.36	16.81	3.85	9.51	8.88	7.53	5.97	4.18	4.62
CFO/Avg Current Liab	-0.67	-0.73	-0.44	-1.75	-1.17	-1.75	-1.25	10.4	-1.51	-1.33	-4.11	-3.96	-3.22	-3.12	-3.63
Common Equity/Total Assets	32.61	9.45	-20.69	8.23	1.29	15.49	17.26	79.88	71.07	70.01	60.82	51.6	32.91	19.99	32.04
Long-Term Debt/Equity (%)	7.37	290.54	- -	355.44	3,776.2	276.27	279.19	14.38	10.16	12.66	18.5	30.77	75.21	136.15	72.64
Long-Term Debt/Capital (%)	3.41	74.39	285.01	75.97	95.6	72.79	73.63	12.57	7.87	11.11	15.28	22.65	39.6	50.64	37.17
Long-Term Debt/Total Assets (%)	2.4	27.44	30.62	29.24	48.69	42.8	48.19	11.49	7.22	8.86	11.25	15.88	24.75	27.22	23.27
Total Debt/Equity (%)	116.04	290.54	-151.92	367.86	3,850.18	279.57	279.19	14.38	29.04	13.95	21.07	35.87	89.91	168.87	95.46
Total Debt/Capital (%)	53.71	74.39	292.59	78.63	97.47	73.65	73.63	12.57	22.51	12.24	17.4	26.4	47.34	62.81	48.84
Total Debt/Total Assets (%)	37.84	27.44	31.43	30.26	49.64	43.31	48.19	11.49	20.64	9.77	12.82	18.5	29.59	33.75	30.58
CFO/Total Liabilities	-27.83	-28.79	-7.35	-35.04	-14.85	-24.34	-19.1	166.02	-57.47	-67.89	-94.28	-88.38	-72.12	-72.27	-109.41
CFO/CapEx	-11.7	-12.26	-9.42	-14.23	-6.53	-18.31	-8.31	50.44	-12.5	-43.16	-27.53	-53.56	-222.67	-119.69	-1,219.36
Altman's Z-Score	-3.39	-4.31	-5.42	-2.7	-2.28	-2.96	7.85	9.4	2.59	1.86	-0.87	-6.53	-12.04	-16.44	-16.49

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.76	15.12	37.07	68.78	19.6	9.29	29.74	49.49	2.86	4.04	3.32	6.47	25.08	163.36	- -
Days Sales Outstanding	76.7	24.15	9.85	5.31	18.63	39.3	12.27	7.38	127.4	90.34	109.92	56.45	14.55	2.23	- -
Inventory Turnover	2.2	1.97	2.43	2.16	2.81	2.69	2.8	2.21	1.78	1.39	1.6	1.24	1.91	3.81	- -
Days Inventory Outstanding	166.08	185.48	150.33	168.88	130.03	135.63	130.45	165.27	205.31	261.96	227.92	295.26	190.8	95.76	- -
Accounts Payable Turnover	5.34	12.25	5.63	4.74	12.83	11.58	7.94	4.71	1.81	1.07	1.59	2.2	2.69	1.36	- -
Accounts Payable Turnover Days	68.32	29.78	64.88	76.94	28.45	31.53	45.97	77.44	202.07	341.59	229.05	165.67	135.85	267.88	- -
Cash Conversion Cycle	174.46	179.84	95.29	97.25	120.21	143.4	96.75	95.21	130.65	10.7	108.79	186.04	69.5	-169.88	- -
Inventory to Cash Days	-89.39	-161.33	-140.49	-163.58	-111.41	-96.33	-118.18	-157.89	-77.91	-171.62	-117.99	-238.82	-176.24	-93.52	- -
Inventories	13	18	13	13	11	11	11	11	13	15	16	19	16	- -	- -
Raw Materials	7	7	4	2	3	2	2	2	2	2	3	3	2	- -	- -
Work In Process	4	7	6	5	6	7	5	6	8	11	9	11	13	- -	- -
Finished Goods	2	4	3	6	2	2	4	3	3	2	3	6	1	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	641	854	1,322	2,034	2,280	1,880	9,527	5,704	3,811	3,062	2,506	426	108	173	862
- Cash & Cash Equivalents	15	25	39	12	56	60	5	195	96	199	25	88	35	44	15
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	230	137	137	134	248	246	245	247	408	150	143	131	118	103	86
Enterprise Value	629	713	1,222	1,930	2,218	1,737	9,476	4,616	2,894	2,150	1,915	53	-78	20	702
Total Capital	427	184	47	170	254	334	333	1,965	1,814	1,228	823	498	249	163	176
Total Debt/Capital (%)	53.71	74.39	292.59	78.63	97.47	73.65	73.63	12.57	22.51	12.24	17.4	26.4	47.34	62.81	48.84
Total Debt / EV	0.36	0.19	0.11	0.07	0.11	0.14	0.03	0.05	0.14	0.07	0.07	2.5	-1.52	5.1	0.12
EV/Sales	8.81	8.79	8.2	9.61	9.61	10.5	30.79	3.87	25.25	14.06	18.79	0.57	- -	0.2	12.7
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	6.6	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	6.71	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	435.14	- -	- -	- -	- -	6.07	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	177.1	- -	- -	- -	- -	5.95	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	632	851	1,314	1,967	2,232	1,713	9,314	5,921	3,778	3,036	2,476	423	107	191	713
Diluted Enterprise Value	847	962	1,411	2,088	2,424	1,900	9,554	5,973	4,090	2,987	2,594	466	190	250	784
EV per Share	82.48	92.85	157.32	220.59	245.94	170.08	891.01	398.97	245.94	179.07	154.87	4.19	- -	1.62	34.43
TTM Sales	71	81	149	201	231	165	308	1,193	115	153	102	92	90	98	55
TTM EBITDA	-109	-125	-106	-4	-17	-98	-29	699	-427	-366	-432	-227	-127	-126	-130
TTM Operating Income	-124	-140	-120	-16	-29	-113	-44	688	-440	-380	-446	-240	-135	-130	-131
TTM Cash Flow to Firm	-103	-96	3	-104	-34	-75	-39	761	-282	-276	-365	-275	-167	-148	-182
TTM Free Cash Flow to Firm	-94	-86	7	-94	-23	-68	-30	775	-256	-269	-350	-269	-166	-146	-182

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-6.08	-7.14	-38.14	-14.89	-36.06	-15.48	-131.66	8.08	-12.49	-9.92	-6.23	-1.42	-0.56	-1.1	-3.42
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	6.71	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	629	713	1,222	1,930	2,218	1,737	9,476	4,616	2,894	2,150	1,915	53	-78	20	702
Low Price	61.05	83.4	111.45	151.5	137.4	157.8	171.15	438.3	234.6	204.45	158.85	29.85	6.19	7.2	6.48
EV/Sales	8.81	8.79	8.2	9.61	9.61	10.5	30.79	3.87	25.25	14.06	18.79	0.57	- -	0.2	12.7
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	6.6	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	8.18	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-6.39	-5.22	-7.62	-30.61	-20.66	-13.3	-38.18	16.14	-11.53	-7.99	-6.08	-2.69	-0.66	-1.97	-2.94
Price/Earnings High	-10.92	-7.34	-10.34	-41.25	-28.64	-18.17	-99.81	27.72	-18.71	-11.49	-9.36	-7.15	-2.2	-3.34	-6.88
Price/Earnings Low	-3.43	-3.71	-5.31	-23.77	-14.95	-9.57	-18.4	7.27	-6.21	-5.48	-3.71	-1.01	-0.28	-0.83	-0.67
Price/Book Value	3.24	18.16	-14.71	55.98	354.58	21.33	108.47	3.32	2.71	2.84	3.69	1.16	0.83	2.84	9.59
Price/Book Value Average	4.38	19.15	-13.82	46.97	266.44	25.44	42.99	6.55	3.65	3.33	4.74	2.72	1.41	3.49	6.5
Price/Book Value High	7.49	26.92	-18.75	63.31	369.31	34.74	112.39	11.25	5.92	4.78	7.3	7.23	4.66	5.9	15.18
Price/Book Value Low	2.36	13.63	-9.63	36.48	192.76	18.29	20.72	2.95	1.96	2.28	2.89	1.02	0.6	1.47	1.47
Price/Tangible Book Value	5.28	-28.97	-7.95	-50.63	-32.53	161.73	841.07	3.48	2.87	3.06	4.16	1.47	0.83	2.84	9.59
Price/Tangible Book Value Average	7.15	-30.54	-7.47	-42.49	-24.45	192.86	333.34	6.86	3.86	3.58	5.35	3.44	1.41	3.49	6.5
Price/Tangible Book Value High	12.22	-42.92	-10.13	-57.26	-33.88	263.35	871.49	11.78	6.26	5.15	8.23	9.14	4.66	5.9	15.18
Price/Tangible Book Value Low	3.84	-21.74	-5.2	-32.99	-17.69	138.66	160.69	3.09	2.08	2.45	3.26	1.29	0.6	1.47	1.47
Price/Sales	8.85	10.48	8.82	9.8	9.67	10.35	30.27	4.67	32.96	19.85	24.3	4.59	1.19	1.94	12.91
Price/Sales Average	11.97	11.05	8.29	8.22	7.27	12.35	12	9.22	44.34	23.23	31.26	10.77	2.04	2.39	8.75
Price/Sales High	20.46	15.53	11.25	11.08	10.07	16.86	31.36	15.83	71.93	33.4	48.11	28.58	6.73	4.03	20.44
Price/Sales Low	6.43	7.86	5.77	6.38	5.26	8.88	5.78	4.15	23.88	15.92	19.05	4.05	0.87	1	1.98
Price/Cash Flow	-5.56	-6.56	-34.09	-13.85	-30.54	-14.64	-115.82	7.76	-11.49	-9.69	-6	-1.39	-0.56	-1.09	-3.42
Price/Cash Flow Average	-7.52	-6.91	-32.04	-11.62	-22.95	-17.45	-45.9	15.32	-15.46	-11.34	-7.72	-3.26	-0.95	-1.34	-2.32
Price/Cash Flow High	-12.86	-9.72	-43.47	-15.66	-31.81	-23.83	-120.01	26.3	-25.08	-16.3	-11.88	-8.65	-3.15	-2.26	-5.41
Price/Cash Flow Low	-4.04	-4.92	-22.32	-9.02	-16.6	-12.55	-22.13	6.9	-8.33	-7.77	-4.7	-1.22	-0.41	-0.56	-0.52
Price/Free Cash Flow Average	-8.23	-7.53	-35.85	-12.5	-27.1	-18.46	-52.18	15.95	-16.8	-11.61	-8.01	-3.32	-0.96	-1.35	-2.32
Price/Free Cash Flow High	-14.06	-10.58	-48.63	-16.85	-37.56	-25.21	-136.42	27.38	-27.26	-16.69	-12.33	-8.82	-3.16	-2.28	-5.42
Price/Free Cash Flow Low	-4.42	-5.36	-24.97	-9.71	-19.61	-13.27	-25.16	7.19	-9.05	-7.95	-4.88	-1.25	-0.41	-0.57	-0.52
EV/Sales Average	15.13	12.46	9	9.11	8.25	14.68	13.05	9.47	47.44	23.11	32.79	11.32	2.97	2.75	11.85
EV/Sales High	23.74	16.96	11.97	12.06	11.12	19.63	32.86	16.24	75.27	33.36	49.84	29.27	7.69	4.24	25.97
EV/Sales Low	9.52	9.26	6.47	7.21	6.2	10.87	6.7	4.29	26.81	15.73	20.43	4.55	1.79	1.5	3.67
EV/EBITDA Average	-9.92	-8.09	-12.66	-513.75	-115.34	-24.91	-138.87	16.18	-12.74	-9.66	-7.74	-4.59	-2.1	-2.15	-5.04
EV/EBITDA High	-15.57	-11.01	-16.85	-680.58	-155.38	-33.31	-349.65	27.73	-20.21	-13.95	-11.76	-11.86	-5.44	-3.32	-11.06
EV/EBITDA Low	-6.24	-6.02	-9.1	-406.57	-86.66	-18.45	-71.25	7.33	-7.2	-6.58	-4.82	-1.84	-1.27	-1.17	-1.56
EV/EBIT Average	-8.73	-7.25	-11.16	-110.88	-64.86	-21.52	-91.99	16.44	-12.36	-9.3	-7.49	-4.34	-1.98	-2.08	-5
EV/EBIT High	-13.69	-9.87	-14.84	-146.89	-87.37	-28.78	-231.6	28.17	-19.61	-13.43	-11.39	-11.22	-5.12	-3.21	-10.97
EV/EBIT Low	-5.49	-5.39	-8.02	-87.75	-48.73	-15.94	-47.2	7.45	-6.98	-6.33	-4.67	-1.74	-1.19	-1.14	-1.55
Last Price	84	111.15	170.25	232.5	252.75	184.05	895.8	493.05	323.85	255	202.65	33.9	8.48	13.95	42.28
High Price	194.25	164.7	217.05	262.95	263.25	299.7	928.2	1,670.4	706.65	429	401.25	210.9	47.85	28.95	66.92
Enterprise Value Average	1,082	1,011	1,340	1,828	1,905	2,429	4,016	11,307	5,437	3,534	3,341	1,042	267	270	654
Enterprise Value High	1,697	1,377	1,783	2,422	2,566	3,248	10,112	19,376	8,627	5,102	5,079	2,694	693	417	1,434
Enterprise Value Low	680	752	963	1,447	1,431	1,799	2,061	5,123	3,072	2,406	2,082	419	161	147	203

Shares Outstanding	8	8	8	9	9	10	11	12	12	12	12	13	13	12	20
Diluted Weighted Avg Shares	8	8	8	8	9	9	10	12	12	12	12	12	13	14	17
Basic Weighted Avg Shares	8	8	8	8	9	9	10	11	12	12	12	12	13	14	17
Revenue per Share	9.49	10.61	19.3	23.73	26.13	17.78	29.6	105.54	9.82	12.84	8.34	7.38	7.11	7.18	3.27
EBITDA per Share	-14.47	-16.33	-13.72	-0.42	-1.87	-10.48	-2.78	61.8	-36.59	-30.72	-35.35	-18.21	-10.06	-9.16	-7.69
Operating Income per Share	-16.46	-18.23	-15.57	-1.95	-3.33	-12.13	-4.2	60.84	-37.72	-31.91	-36.51	-19.26	-10.68	-9.48	-7.75
Basic EPS, GAAP	-17.79	-22.45	-21	-6.37	-9.19	-16.5	-9.3	60.26	-37.77	-37.33	-42.87	-29.51	-21.79	-8.68	-9.73
Basic EPS from Cont Ops	-17.79	-22.45	-21	-6.37	-9.19	-16.5	-9.3	60.26	-37.77	-37.33	-42.87	-29.51	-21.79	-8.68	-9.73
Diluted EPS, GAAP	-17.79	-22.45	-21	-6.37	-9.19	-16.5	-9.3	56.74	-37.77	-37.33	-42.87	-29.51	-21.79	-8.68	-9.73
Diluted EPS from Cont Ops	-17.79	-22.45	-21	-6.37	-9.19	-16.5	-9.3	56.74	-37.77	-37.33	-42.87	-29.51	-21.79	-8.68	-9.73
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-15.11	-16.95	-4.99	-16.79	-8.28	-12.57	-7.73	63.52	-28.17	-26.31	-33.77	-24.37	-15.21	-12.82	-12.36
Free Cash Flow per Basic Share	-16.4	-18.33	-5.52	-17.97	-9.54	-13.26	-8.67	62.26	-30.43	-26.92	-35	-24.82	-15.27	-12.92	-12.37
Cash & Equivalents per Share	31.6	36.07	30.52	27.19	34.25	38.09	27.85	115.43	112.59	88.45	59.36	40.17	23.8	20.61	12.06
Book Value per Share	25.92	6.12	-11.58	4.15	0.71	8.63	8.26	148.47	119.43	89.73	54.96	29.17	10.27	4.9	4.41
Tangible Book Value per Share	15.89	-3.84	-21.43	-4.59	-7.77	1.14	1.07	141.86	112.93	83.36	48.77	23.08	10.27	4.9	4.41

Nektar Therapeutics

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)